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ABSTRACT 
Compared to sugars, a major advantage of using glycerol as a feedstock for industrial bioprocesses is 
the fact that this molecule is more reduced than sugars. A compound whose biotechnological 
production might greatly profit from the substrate’s higher reducing power is 1,2-propanediol (1,2-
PDO). Here we present a novel metabolic engineering approach to produce 1,2-PDO from glycerol in 
S. cerevisiae. Apart from implementing the heterologous methylglyoxal (MG) pathway for 1,2-PDO 
formation from dihydroxyacetone phosphate (DHAP) and expressing a heterologous glycerol 
facilitator, the employed genetic modifications included the replacement of the native FAD-
dependent glycerol catabolic pathway by the `DHA pathway´ for delivery of cytosolic NADH and the 
reduction of triosephosphate isomerase (TPI) activity for increased precursor (DHAP) supply. The 
choice of the medium had a crucial impact on both the strength of the metabolic switch towards 
fermentation in general (as indicated by the production of ethanol and 1,2-PDO) and on the ratio at 
which these two fermentation products were formed. For example, virtually no 1,2-PDO but only 
ethanol was formed in synthetic glycerol medium with urea as the nitrogen source. When nutrient-
limited complex YG medium was used, significant amounts of 1,2-PDO were formed and it became 
obvious that the concerted supply of NADH and DHAP are essential for boosting 1,2-PDO production. 
Additionally, optimizing the flux into the MG pathway improved 1,2-PDO formation at the expense of 
ethanol. Cultivation of the best-performing strain in YG medium and a controlled bioreactor set-up 
resulted in a maximum titer of > 4 g L-1 1,2-PDO which, to the best of our knowledge, has been the 
highest titer of 1,2-PDO obtained in yeast so far. Surprisingly, significant 1,2-PDO production was also 
obtained in synthetic glycerol medium after changing the nitrogen source towards ammonium 
sulfate and adding a buffer.  
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1. INTRODUCTION 
A major challenge for the production of chemicals by industrial biotechnology is the fact that the 
commonly used sugar-based substrates inevitably result in low carbon yields which can be attributed 
to the high oxidation state (O:C ratio) of sugars relative to many products (Burk and Van Dien, 2016). 
Although glycerol is still less reduced than hydrocarbons derived from fossil resources, the degree of 
reduction (4.667) is higher than that of common sugars such as glucose (4.000) and xylose (4.000) 
(Yazdani and Gonzalez, 2008). Therefore, the utilization of glycerol as a substrate or co-substrate in 
the fermentative production of chemicals can lead to higher maximum theoretical product yields of 
compounds with a relatively high degree of reduction as well as of molecules whose biochemical 
production from sugars is not redox-neutral but requires additional reducing equivalents such as 1,2-
propandiol or succinic acid (Murarka et al., 2008; Yazdani and Gonzalez, 2007; Zhang et al., 2013).  
Glycerol is an unavoidable by-product of the biodiesel industry since transesterification of vegetable 
oils or animal fats generates app. 10% (w/w) of glycerol (Karinen and Krause, 2006). As a result of the 
growing demand for renewable transportation fuels, the production of biodiesel steadily increased 
during the last decades accompanied by the accumulation of huge amounts of crude glycerol 
(Mattam et al., 2013). In principle, this crude glycerol has to be considered as a waste stream since it 
still contains various residual components from the transesterification process such as methanol, 
NaOH, carry-over fats/oils as well as low amounts of proteins, minerals and sulfur compounds 
(Thompson and He, 2006). The utilization of excess crude glycerol as a feedstock for the microbial 
production of various value-added chemicals in industrial bioprocesses has been considered as a 
promising approach for its valorization (da Silva et al., 2009; Johnson and Taconi, 2007; Yang et al., 
2012).  
The yeast Saccharomyces cerevisiae has become a favorite platform organism for the production of 
various chemical compounds by means of metabolic engineering. In fact, re-routing the carbon flux in 
this organism allowed the commercial production of advanced biofuels (e.g. isoprenoids, isobutanol), 
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bulk chemicals (e.g. succinic acid) as well as pharmaceuticals and neutraceuticals (Borodina and 
Nielsen, 2014; Hong and Nielsen, 2012; Nevoigt, 2008). Major factors driving the increasing 
metabolic engineering incentives in S. cerevisiae are its robustness in industrial setups and its easy 
accessibility for genetic engineering including the tremendous developments with regard to DNA 
assembly, chromosomal engineering and genome editing as comprehensively reviewed by Chao et al. 
(2015) and David and Siewers (2015). 
Most of the commonly employed industrial and laboratory strains of S. cerevisiae utilize glycerol only 
in the presence of complex medium supplements such as amino acids and nucleic bases but do not 
grow in synthetic medium containing glycerol as the sole carbon source (Merico et al., 2011; Swinnen 
et al., 2013). Therefore, glycerol has been rather neglected as a feedstock for S. cerevisiae-based 
bioprocesses. Still, certain wild-type S. cerevisiae isolates including the strain CBS 6412 are able to 
moderately grow in synthetic glycerol medium and a haploid segregant of this strain (CBS 6412-13A) 
showed a maximum specific growth rate (µmax) of ~0.13 h
-1 (Swinnen et al., 2013). The genetic 
determinants underlying the latter segregant’s positive phenotype with regard to growth on glycerol 
in comparison to the non-growing popular laboratory strain CEN.PK113-1A have been unraveled 
recently (Swinnen et al., 2016). Moreover, the maximum specific growth rate of CBS 6412-13A in 
synthetic glycerol medium has been even further improved up to ~0.18 h-1 by the expression of a 
glycerol facilitator (Klein et al., 2016b). Several facilitators originating from various yeast species that 
naturally show superior growth in glycerol medium as compared to S. cerevisiae (such as 
Cyberlindnera jadinii, Yarrowia lipolytica, Pachysolen tannophilus and Komagataella phaffii syn. 
Pichia pastoris) had a similar positive effect on glycerol utilization. 
Wild-type S. cerevisiae strains exclusively utilize the so-called G3P (L-glycerol-3-phosphate) pathway 
for catabolizing glycerol as recently reviewed by Klein et al. (2016c). This pathway transfers the 
electrons derived from G3P oxidation directly via FADH2 to the cell’s mitochondrial respiratory chain 
thereby ‘squandering’ the substrate’s aforementioned superior reducing power. In fact, the 
respective electrons have to be available in the form of cytosolic NADH in order to support the 
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formation of reduced fermentation products. Recently, we replaced the endogenous G3P glycerol 
catabolic pathway by the so-called DHA pathway which transfers the electrons to cytosolic NAD+ 
thereby delivering NADH for fermentative pathways (Klein et al., 2016a; Nevoigt, 2017). S. cerevisiae 
strains engineered in this way show similar or even better glycerol utilization as compared to the 
corresponding wild-type strains offering the possibility to employ the pathway replacement 
approach for the production of reduced chemicals from glycerol in S. cerevisiae. 
1,2-propanediol (1,2-PDO, propylene glycol) is one example for a reduced compound (degree of 
reduction per Cmol: 5.333), whose biotechnological production may greatly profit from using glycerol 
as a feedstock. 1,2-PDO is an important commodity chemical applied in food, drug, and cosmetic 
industries. It is frequently used for the preparation of unsaturated polyester resins, for the 
production of biodegradable plastics, as a solvent in photographic industries, as an aircraft de-icing 
fluid and due to its lower toxicity as an environmentally friendly substitute for ethylene glycol in 
automotive antifreeze (Berrios-Rivera et al., 2003; Niimi et al., 2011; Shelley, 2007). A wide range of 
bacteria is naturally able to produce 1,2-PDO by fermentation, such as Thermoanaerobacterium 
thermosaccharolyticum (Cameron and Cooney, 1986), Clostridium sphenoides (Tran-Din and 
Gottschalk, 1985), Bacteroides ruminocola (Turner and Roberton, 1979), Klebsiella pneumoniae 
(Badia et al., 1985) and E. coli (Boronat and Aguilar, 1979; Boronat and Aguilar, 1981; Gonzalez et al., 
2008; Murarka et al., 2008). Interestingly, there has also been a very early report about some aerobic 
1,2-PDO production by several non-conventional yeast species (Suzuki and Onishi, 1968) and small 
amounts have been detected in several industrial S. cerevisiae strains (Dowd et al., 1994). However, 
one has to note that a full metabolic pathway for the production of 1,2-PDO has never been 
identified in yeast. In addition, the respective cultivations were performed in undefined media which 
may contain one or several of the pathway intermediates. These intermediates could have been 
converted to 1,2-PDO by endogenous, non-specific oxidoreductase activities (Bennett and San, 
2001). 
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Two main natural biochemical pathways leading to 1,2-PDO production have been discovered in 
bacteria. A widely spread pathway, which exists for example in E. coli and Salmonella typhimurium, 
depends on the fermentation of the deoxy hexose sugars L-rhamnose and L-fucose (Badia et al., 
1985; Bennett and San, 2001; Boronat and Aguilar, 1981). A second natural route identified in 
T. thermosaccharolyticum and C. sphenoides converts the glycolytic carbon intermediate 
dihydroxyacetone phosphate (DHAP) by a methylglyoxal synthase (MGS) to methylglyoxal (MG) 
followed by two subsequent NAD(P)H dependent reductions catalyzed by aldo-keto reductases 
(AKRs) to 1,2-PDO (see Figure 1) (Bennett and San, 2001; Cameron and Cooney, 1986; Tran-Din and 
Gottschalk, 1985). 1,2-PDO formation by wild-type E. coli had been originally assumed to be 
restricted to the fermentation of the deoxy hexose sugars as mentioned above. However, more 
recent studies demonstrated that the so-called ʽmethylglyoxal pathwayʼ is also used in E. coli to 
anaerobically ferment glycerol where 1,2-PDO production is used as a redox sink in order to cope 
with the surplus cytosolic NADH derived from biomass formation (Gonzalez et al., 2008; Murarka et 
al., 2008). As the latter pathway allows for the production of 1,2-PDO from inexpensive sugars or 
glycerol it has been the preferred route in the context of rational engineering of microorganisms for 
1,2-PDO production. So far, the bacterium E. coli has been the mainly employed chassis in numerous 
engineering studies aiming at the fermentative production of 1,2-PDO using either glucose (Altaras 
and Cameron, 1999; Altaras and Cameron, 2000; Berrios-Rivera et al., 2003; Cameron et al., 1998; 
Huang et al., 1999; Jain et al., 2015a; Jain et al., 2015b; Lee et al., 2016) or glycerol (Clomburg and 
Gonzalez, 2011) as the sole carbon source. The ʽmethylglyoxal pathwayʼ was also used to produce 
1,2-PDO from glucose in engineered cells of Corynebacterium glutamicum (Niimi et al., 2011; Siebert 
and Wendisch, 2015) and from CO2 by metabolic engineering of the cyanobacterium Synechococcus 
elongatus (Li and Liao, 2013). Eukaryotic microorganisms previously engineered for 1,2-PDO 
production include S. cerevisiae (Jeon et al., 2009; Jung et al., 2008; Jung et al., 2011; Lee and DaSilva, 
2006) and K. phaffii (P. pastoris) (Barbier et al., 2011). Notably, the highest titers of 1,2-PDO such as 
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5.62 g/L for E. coli (Clomburg and Gonzalez, 2011) and 2.19 g/L for S. cerevisiae (Jung et al., 2011) 
were achieved when using glycerol as the carbon source.  
Here, we present a novel metabolic engineering study for the production of 1,2-PDO from glycerol in 
the yeast S. cerevisiae. The current work was initiated since we assumed that our previously reported 
glycerol catabolic pathway replacement (Klein et al., 2016a) might be crucial for providing sufficient 
amounts of cytosolic NADH for the production of reduced chemicals such as 1,2-PDO. Apart from 
obtaining the highest 1,2-PDO titer produced in yeast so far, we also got surprising new insights into 
the physiology of glycerol metabolism in our engineered strains including unexpected effects caused 
by the medium composition. 
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Figure 1 (2 column fitting image). Metabolic engineering for 1,2-propanediol (1,2-PDO) production from 
glycerol in S. cerevisiae. Module `PDO´: `methylglyoxal pathway´ converting dihydroxyacetone phosphate 
(DHAP) via methylglyoxal to 1,2-PDO by expressing E. coli methylglyoxal synthase (encoded by EcmgsA), E. coli 
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aldehyde reductase (encoded by EcyqhD) and E. coli glycerol dehydrogenase (encoded by EcgldA). Module 
`DHA´: replacement of the native FAD-dependent glycerol catabolic pathway via L-glycerol-3-phosphate by the 
NAD+-dependent `DHA pathway´ by deletion of the gene encoding glycerol kinase (GUT1), expression of a 
glycerol dehydrogenase from O. parapolymorpha (Opgdh) and overexpression of endogenous 
dihydroxyacetone kinase (encoded by DAK1). Module `TPI1down´: downregulation of the expression of TPI1 
encoding triosephosphate isomerase by replacement of the gene’s native promoter by the weak TEF1 
promoter variant TEFmut2 (Nevoigt et al., 2006). All constructed S. cerevisiae strains express the glycerol 
facilitator from C. jadinii encoded by CjFPS1 in addition to the endogenous glycerol/H+ symporter encoded by 
STL1. The latter modification has been considered to be useful as it resulted in a significantly improved glycerol 
uptake in the genetic background of CBS 6412-13A (Klein et al., 2016b). Bold grey arrows highlight the carbon 
flux from glycerol to 1,2-PDO as it is assumed based on the published knowledge regarding the in vivo and/or in 
vitro activities of transport and enzymes as explained in the main text. Still, it has to be considered that the 
heterologous enzymes encoded by EcgldA, EcyqhD and Opgdh have relatively broad substrate specificities and 
might also contribute to other reduction/oxidation reactions in addition those allocated to the gene names in 
this Figure. Moreover, unspecific/uncharacterized endogenous enzyme activities in S. cerevisiae might also 
contribute to the different potential reactions from methylglyoxal to 1,2-PDO.  
 
2. MATERIALS AND METHODS 
2.1 Strains and their maintenance 
All S. cerevisiae strains used in this study were based on CBS 6412-13A (Swinnen et al., 2013) and are 
listed in Table 1. The yeast strains were routinely grown on solid YPD medium containing 10 g L-1 
yeast extract, 20 g L-1 peptone, 20 g L-1 glucose, and 15 g L-1 agar. All strains, whose native TPI1 
promoter had been replaced by the engineered TEF1 promoter variant TEFmut2, were grown on 
solid YP glycerol medium (YPG) containing 30 g L-1 glycerol as the carbon source. If required, solid 
medium was supplemented with G418 (200 mg L-1), phleomycin (20 mg L-1), nourseothricin 
(100 mg L-1) or hygromycin B (300 mg L-1). E. coli DH5α was used for plasmid construction and 
isolation, and cells were routinely grown in lysogeny broth (LB) (10 g L-1 peptone, 5 g L-1 yeast extract 
and 10 g L-1 NaCl, pH 7.0). For selection and maintenance of plasmid containing cells, 100 mg L-1 
ampicillin was added. 
2.2 General molecular biology techniques 
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All primers used within the present study are listed in Table S1 (supplementary information). 
Preparative PCRs for cloning were performed using Phusion® High-Fidelity DNA Polymerase (New 
England BioLabs, Frankfurt am Main, Germany) or AccuPrime Pfx DNA polymerase (Thermo Fisher 
Scientific, Waltham, MA, USA). PCR conditions were adapted to the guidelines of the respective 
manufacturer. Restriction enzymes, FastAP alkaline phosphatase and T4 DNA ligase were obtained 
from Thermo Fisher Scientific and used according to the manufacturer’s instructions. PCR products 
were purified by using the QIAquick PCR Purification Kit (Qiagen, Hilden, Germany) and DNA 
fragments obtained after restriction were excised and purified using the QIAquick Gel Purification Kit 
(Qiagen). Plasmids were isolated from E. coli DH5α overnight cultures using the QIAprep Spin 
Miniprep Kit (Qiagen). Transformation of S. cerevisiae with plasmids as well as with linear DNA 
fragments for genomic integration was performed according to the lithium acetate method 
described by Gietz et al. (1995). 
Table 1: Strains used in this study. 
Strain / Modules Genome modifications Plasmid Source or reference 
CBS 6412-13A - - Swinnen et al. (2013) 
CBS 6412-13A CjFPS1 YGLCτ3:: TEF1p-CjFPS1-CYC1t - Klein et al. (2016b) 
CBS 6412-13A DAK1OE 
gut1Δ 
YPRCΔ15::ACT1p-DAK1-TPS1t;  
gut1::loxP-kanMX4-loxP 
- Klein et al. (2016a) 
FPS YGLCτ3:: TEF1p-CjFPS1-CYC1t p41ble-E-E This study 
PDO-FPS YGLCτ3::TEF1p-EcmgsA-CYC1t:TDH3p-EcgldA-IDP1t-
PGK1p-CjFPS1-RPL15At 
p41ble-E-yqhD 
(ACT1p-EcyqhD-TPS1t) 
This study 
PDO-FPS-DHA YGLCτ3::TEF1p-EcmgsA-CYC1t:TDH3p-EcgldA-IDP1t-
PGK1p-CjFPS1-RPL15At; YPRCΔ15::ACT1p-DAK1-
TPS1t; gut1::loxP-kanMX4-loxP 
p41ble-gdh-yqhD 
(TEF1p-Opgdh-CYC1t; 
ACT1p-EcyqhD-TPS1t) 
This study 
PDO-FPS-TPI1down YGLCτ3::TEF1p-EcmgsA-CYC1t:TDH3p-EcgldA-IDP1t-
PGK1p-CjFPS1-RPL15At; tpi1p::TEFmut2p-TPI1 
p41ble-E-yqhD 
(ACT1p-EcyqhD-TPS1t) 
This study 
PDO-FPS-TPI1down-DHA YGLCτ3::TEF1p-EcmgsA-CYC1t:TDH3p-EcgldA-IDP1t-
PGK1p-CjFPS1-RPL15At; tpi1p::TEFmut2p-TPI1; 
YPRCΔ15::ACT1p-DAK1-TPS1t; gut1::loxP-kanMX4-
loxP 
p41ble-gdh-yqhD 
(TEF1p-Opgdh-CYC1t; 
ACT1p-EcyqhD-TPS1t) 
This study 
PDO-FPS-TPI1down-DHA 
EcmgsA2 
YGLCτ3::TEF1p-EcmgsA-CYC1t:TDH3p-EcgldA-IDP1t-
PGK1p-CjFPS1-RPL15At; tpi1p::TEFmut2p-TPI1; 
YPRCΔ15::ACT1p-DAK1-TPS1t; gut1::loxP-kanMX4-
loxP; YPRCτ3::TDH3p-EcmgsA-IDP1t: TEF1p-Opgdh-
CYC1t; YORWΔ22:: ACT1p-EcyqhD-TPS1t 
- This study 
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2.3 Construction of plasmids and expression cassettes 
All constructed plasmids are listed in Table S2 (supplementary information). Codon-optimized coding 
sequences for E. coli mgsA, gldA and yqhD were obtained via GeneArtTM gene synthesis from Thermo 
Fisher Scientific (Waltham, MA, USA). The plasmids for either the sole expression of E. coli yqhD 
(EcyqhD) under the control of the ACT1 promoter and the TPS1 terminator or its expression in 
combination with the O. parapolymorpha gdh (Opgdh), under the control of the TEF1 promoter and 
the CYC1 terminator, were obtained by using Gibson isothermal assembly (Gibson et al., 2009). The 
assembly was performed in the previously constructed S. cerevisiae expression vectors p41bleTEF or 
p41bleTEF-Opgdh (Klein et al., 2016a). The ACT1 promoter and the TPS1 terminator sequences were 
amplified from genomic DNA isolated from the S. cerevisiae strain S288c using primers 531 and 532, 
and 533 and 534, respectively (see Table S1). The coding sequence of E. coli yqhD was amplified from 
pMA-T-yqhD (Table S2) using primers 535 and 536, and the template vector was subsequently 
removed by digestion with DpnI. The assembly reactions contained 15 μL of the reagent-enzyme mix, 
0.05 pmol of KpnI-linearized and dephosphorylated p41bleTEF or p41bleTEF-Opgdh and 3-fold molar 
excess of the inserts (promoter, coding sequence and terminator each 0.15 pmol) in a final volume of 
20 µL. Reaction mixtures were incubated at 50°C for 1 h. E. coli DH5α cells were transformed with 
5 μL of the reaction and the resulting vectors named p41ble-E-yqhD and p41ble-gdh-yqhD where “E” 
specifies an empty expression cassette consisting solely of the TEF1 promoter and CYC1 terminator 
sequences (Table S2). The empty vector control (carrying two empty expression cassettes) was 
constructed accordingly by assembling only the ACT1 promoter and the TPS1 terminator in 
p41bleTEF. The primers used for amplification were 531 and 538, and 533 and 537, respectively. The 
resulting ‘empty’ vector was named p41ble-E-E and used for the construction of control strains. 
The expression cassettes for C. jadinii FPS1 (CjFPS1) and S. cerevisiae DAK1 (ScDAK1) for genomic 
integration were obtained by PCR amplification from the plasmids pUC18-CjFPS1 and pUC18-DAK1 
(Table S2). Construction of these plasmids is described in Klein et al. (2016a). One of the two 
expression cassettes constructed for integrating E. coli mgsA into the genome (EcmgsA under the 
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control of the S. cerevisiae TEF1 promoter and the CYC1 terminator) was obtained by cloning the 
respective coding sequence into the multiple cloning site of p416TEF-KanMX (Table S2). For this 
purpose the EcmgsA coding sequence was amplified from pMA-T-mgs (Table S2) using primers 276 
and 277. The cloning via BamHI and EcoRI yielded the plasmid p416TEF-mgsA-KanMX. The second 
EcmgsA expression cassette (EcmgsA2 under the control of the TDH3 promoter and the IDP1 
terminator) and the cassette for expression of E. coli gldA (EcgldA) (also under the control of the 
TDH3 promoter and the IDP1 terminator) were both assembled in pUC18 using Gibson isothermal 
assembly (Gibson et al., 2009). Promoters and terminators were amplified from genomic DNA 
isolated from the S. cerevisiae strain S288c using primer combinations 413/419 and 415/328 for the 
expression cassette of EcmgsA2, and 324/323 and 327/328 for the expression cassette of EcgldA. The 
coding sequences for EcmgsA and EcgldA were amplified from the plasmids pMA-T-mgs and pGA-
gldA using primer combinations 420/414 and 325/326, respectively. Both template vectors were 
removed after PCR by digestion with DpnI. The target vector pUC18 was linearized using BamHI and 
subsequently dephosphorylated to avoid self-ligation. The further steps for assembly and 
transformation were the same as described above and the resulting plasmids named pUC18-gldA and 
pUC18-mgsA. All constructed plasmids were verified by Sanger sequencing (GATC Biotech, Konstanz, 
Germany). 
2.4 Plasmids for CRISPR-Cas9 mediated genome editing in S. cerevisiae 
For CRISPR-Cas9 mediated genome editing, the plasmids p414-TEF1p-Cas9-CYC1t-nat1 and p426-
SNR52p-gRNA.CAN1.Y-SUP4t-hphMX (Table S2) were used. Construction of the respective plasmids 
has been reported by Klein et al. (2016a). The specific 20 nt sequence at the 5’-end of the gRNA 
targeting the CAN1 gene was exchanged in p426-SNR52p-gRNA.CAN1.Y-SUP4t-hphMX by a 20 nt 
sequence targeting the YGLCτ3 region on chromosome VII (Flagfeldt et al., 2009) by generating two 
overlapping PCR products of the gRNA expression cassette and their subsequent assembly in the 
same vector backbone according to Gibson et al. (2009). The target sequence within the YGLCτ3 
locus was selected after analysis of the respective genomic region using the CRISPRdirect online tool 
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developed by Naito et al. (2015). The two overlapping fragments of the gRNA expression cassette 
were obtained by PCR amplification from p426-SNR52p-gRNA.CAN1.Y-SUP4t (Table S2) using primers 
460 and 464, and 465 and 463, respectively (Table S1), where the 5’-termini of primers 464 and 465 
generated flanking sequences at the ends of the two PCR products which overlapped with the 
YGLCτ3 target sequence for genomic integration. The primers 460 and 463 contained 5’-extensions 
resulting in overlaps with PvuII-linearized p426-SNR52p-gRNA.CAN1.Y-SUP4t-hphMX. The accordingly 
digested vector was gel-purified and Gibson isothermal assembly was performed as described above 
(section 2.3) yielding p426-SNR52p-gRNA.YGLCτ3-SUP4t-hphMX. 
2.5 S. cerevisiae strain construction 
A detailed scheme for the construction of engineered CBS 6412-13A derivatives (Table 1) is shown in 
Figure S1 (supplementary information). As the expression of EcyqhD and Opgdh in all constructed 
strains except PDO-FPS-TPI1down-DHA EcmgsA2 was plasmid-based, the final step for completion was 
always a transformation with p41ble-E-yqhD, p41ble-gdh-yqhD or p41ble-E-E.  
Strains PDO-FPS and FPS 
As mentioned in section 2.4 the long terminal repeat (LTR) YGLCτ3 on chromosome VII (Flagfeldt et 
al., 2009) was selected as a target site for the genomic integration of the expression cassettes for 
EcmgsA (under the control of the TEF1 promoter and the CYC1 terminator) and EcgldA (under the 
control of the TDH3 promoter and the IDP1 terminator) in CBS 6412-13A. The seamless integration 
was achieved in two steps. First, a counter-selectable, galactose-inducible growth inhibitory 
sequence (referred to as GALp-GIN11M86) and the kanMX4 selectable marker were assembled and 
integrated at the target site by homologous recombination. The GALp-GIN11M86 cassette was 
amplified from plasmid pGG119 (Akada et al., 2002) using primers 175 and 155. The kanMX4 
expression cassette was amplified from plasmid pUG6 (Gueldener et al., 1996) using primers 171 and 
176. The PCR primers were modified at their 5’-ends generating homologous regions of ~40-60 bp at 
the ends of the PCR products for assembly and integration at the target locus. In the second step, the 
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two aforementioned expression cassettes EcmgsA and EcgldA were assembled and integrated by 
homologous recombination at the target locus replacing the entire GALp-GIN11M86/kanMX4 
cassette. The respective expression cassettes were amplified from the previously constructed 
plasmids p416TEFmgsA-KanMX (primers 257 and 302) and pUC18-gldA (primers 303 and 297), 
respectively. Primer pairs were designed to generate PCR products whose flanking sequences were 
homologous to the chromosomal regions upstream and downstream of the previously integrated 
GALp-GIN11M86/kanMX4 cassette. After transformation, cells were plated on solid synthetic 
medium containing 2% (w/v) galactose as the sole carbon source in order to induce the growth 
inhibitory sequence GIN11M86 for counter-selection. The resulting intermediate strain was named 
PDOmin (Figure S1). Subsequently, an expression cassette for CjFPS1 (under the control of the PGK1 
promoter and the RPL15A terminator) was integrated together with a phleomycin resistance marker 
(ble) downstream of EcmgsA and EcgldA. The CjFPS1 cassette was amplified with primers 390 and 
392 from pUC18-CjFPS1, while the ble cassette was amplified from pUG66 (Gueldener et al., 2002) 
using primers 391 and 393. The 5’-termini of the employed primers were designed to allow assembly 
and integration of the generated PCR products into the genome of strain PDOmin, immediately 
downstream of the previously integrated expression cassettes for EcmgsA and EcgldA, and the 
resulting strain was named PDOmin-FPS. The phleomycin resistance cassette was subsequently 
removed from this intermediate strain by using Cre-loxP-mediated recombination according to 
Steensma and Ter Linde (2001) using the Cre-recombinase expressing plasmid pNatCre (Table S2). 
Finally the resulting strain was transformed with p41ble-E-yqhD to yield the strain PDO-FPS. In order 
to generate a control strain without an implemented pathway for 1,2-PDO production the previously 
constructed strain CBS 6412-13A CjFPS1 (Klein et al., 2016b) was transformed with the ‘empty’ vector 
p41ble-E-E (section 2.3; Table S2). 
Strain PDO-FPS-DHA 
In order to combine the modules for the 1,2-PDO pathway and the glycerol catabolic pathway 
replacement (DHA pathway replacing the endogenous G3P pathway) in an FPS1 expressing strain of 
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CBS 6412-13A, the previously generated strain CBS 6412-13A DAK1OE gut1Δ was used as a basis 
(Table 1) (Klein et al., 2016a). First, the expression cassettes for EcmgsA, EcgldA and CjFPS1 were 
integrated into the YGLCτ3 region of this strain by employing the CRISPR-Cas9 system. For this 
purpose, the expression of Cas9 in the strain CBS 6412-13A DAK1OE gut1Δ was achieved by 
transformation with the plasmid p414-TEF1p-Cas9-CYC1t-nat1 (Table S2). The three expression 
cassettes were PCR-amplified from the plasmids p416TEFmgsA-KanMX, pUC18-gldA and pUC18-
CjFPS1 (see section 2.3 and Table S2) using primers pairs 257/302, 303/552, and 550/551, 
respectively. These primers contained 5’-extensions generating 40-60 bp sequences homologous to 
regions directly upstream and downstream of the YGLCτ3 integration locus or to the respective 
adjacent expression cassette (Figure S1). Co-transformation of the expression cassettes and plasmid 
p426-SNR52p-gRNA.YGLCτ3-SUP4t-hphMX into the S. cerevisiae strain expressing the Cas9 
endonuclease resulted in assembly and integration of all three expression cassettes at the target 
locus. Positive transformants were selected on YPD agar containing both nourseothricin and 
hygromycin B as described in section 2.1. Both plasmids were subsequently removed from the 
resulting clone by serial transfers in YPD medium lacking the respective antibiotics. In order to 
complete both modules (1,2-‘PDO’ and ‘DHA’), the resulting intermediate strain was transformed 
with p41ble-gdh-yqhD (see section 2.3) yielding strain PDO-FPS-DHA. 
Strains PDO-FPS-TPI1down and PDO-FPS-TPI1down-DHA 
In order to downregulate TPI1 expression, the gene’s native promoter was replaced by a promoter 
replacement cassette containing the weak TEF1 promoter variant TEFmut2p (Nevoigt et al., 2006). 
The replacement cassette consisting of the kanMX4 selectable marker and the TEFmut2 promoter 
variant was amplified from the plasmid p416-TEFmut2-yECitrine (Table S2) using primers 426 and 
427. The primers contained 5’-extensions of 60 bp homologous to sequences directly upstream and 
downstream of the endogenous TPI1 promoter. Strain PDOmin-FPS (Figure S1) was transformed with 
the amplified cassette leading to the replacement of the endogenous TPI1 promoter by the 
engineered promoter variant TEFmut2. Transformants were selected on medium containing glycerol 
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as the carbon source. Both dominant markers (the ble cassette downstream of CjFPS1 and the 
kanMX4 cassette upstream of TPI1) in the intermediate strain PDOmin-FPS-TPI1down were 
subsequently rescued by Cre-loxP mediated recombination as described for strain PDOmin-FPS (see 
above). The resulting strain was transformed with plasmid p41ble-E-yqhD yielding strain PDO-FPS-
TPI1down. The previous strain (PDOmin-FPS-TPI1down after marker removal) also served as the basis for 
the construction of strain PDO-FPS-TPI1down-DHA (Figure S1). First, the cassette for ScDAK1 
overexpression (ACT1 promoter and TPS1 terminator) was integrated via the two-step seamless 
integration procedure employing the counter-selectable, galactose-inducible growth inhibitory 
sequence GALp-GIN11M86 as described above. The LTR YPRCΔ15 on chromosome XVI (Flagfeldt et 
al., 2009) served as a target site and the GALp-GIN11M86 growth inhibitory sequence (amplified 
from plasmid pGG119 with primers 298 and 155) was first integrated at this position together with 
the phleomycin resistance marker (amplified from plasmid pUG66 with primers 171 and 299) 
(Table S2). The ScDAK1 expression cassette was amplified from plasmid pUC18-DAK1 using primers 
388 and 389 and subsequently integrated at the target locus by homologous recombination replacing 
the entire GALp-GIN11M86/ble cassette. Afterwards, the endogenous GUT1 coding sequence was 
disrupted by integration of the kanMX4 cassette amplified from plasmid pUG6 using primers 111 and 
112 yielding the intermediate strain PDOmin-FPS-TPI1down DAK1OE gut1Δ. Finally, the resulting 
intermediate strain was transformed with plasmid p41ble-gdh-yqhD to finalize the construction of 
the strain PDO-FPS-TPI1down-DHA. 
Strain PDO-FPS-TPI1down-DHA EcmgsA2 
In order to implement a second expression cassette for mgsA into the strain and, at the same time, 
obtain a CBS 6412-13A derivative that carries all above-described genetic modifications for 1,2-PDO 
production in the genome, the strain PDO-FPS-TPI1down-DHA EcmgsA2 was generated (Figure S1). The 
aforementioned intermediate strain PDOmin-FPS-TPI1down DAK1OE gut1Δ was used as a starting point 
for the integration of the second expression cassette for EcmgsA (EcmgsA2, coding sequence under 
the control of the TDH3 promoter and the IDP1 terminator). Similarly to the expression cassettes of 
17 
 
EcmgsA, EcgldA and ScDAK1, the cassette was integrated together with that of Opgdh into the 
genome via the two-step seamless integration procedure described above using the LTR YPRCτ3 on 
chromosome XVI as a target site (Flagfeldt et al., 2009). First, the GALp-GIN11M86 growth inhibitory 
sequence (amplified from plasmid pGG119 with primers 300 and 155) and the phleomycin resistance 
marker (amplified from plasmid pUG66 with primers 171 and 301) were assembled and integrated at 
the target locus by homologous recombination. The whole Galp-GIN11M86/ble cassette was 
subsequently replaced by assembly and integration of the EcmgsA2 and Opgdh expression cassettes 
(amplified with primers 418 and 422 from plasmid pUC18-mgsA and with primers 416 and 421 from 
plasmid p41bleTEF-Opgdh). Subsequently, the above-described expression cassette for E. coli yqhD 
was integrated along with the phleomycin resistance marker at the YORWΔ22 locus (Flagfeldt et al., 
2009) yielding strain PDO-FPS-TPI1down-DHA EcmgsA2 (see Figure S1). The EcyqhD cassette was 
amplified with primers 663 and 664 from plasmid p41ble-E-yqhD, while the ble cassette was 
amplified from plasmid pUG66 (Gueldener et al., 2002) using primers 665 and 666. The 5’-termini of 
the employed primers were designed to allow assembly and integration of the generated PCR 
products at the target site in the genome. 
2.6 Isolation of genomic DNA from S. cerevisiae transformants and diagnostic PCR 
Correct integrations of all expression and disruption cassettes were verified by diagnostic PCR using 
TaKaRa Ex Taq Polymerase and buffer according to the manufacturer’s guidelines (Merck KGaA, 
Darmstadt, Germany). For this purpose, single colonies obtained after transformations were re-
streaked on respective agar plates. Approximately 50 mg of cells from these plates were suspended 
in 200 μL of TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). Subsequently, 300 mg of acid-washed glass 
beads (diameter of 0.425 to 0.6 mm) and 200 μL of phenol:chloroform:isoamyl alcohol (25:24:1) 
were added. The tubes were then vortexed at maximum speed for 2 min and centrifuged at 15,700 g 
for 10 min according to a protocol modified from Hoffman and Winston (1987). The aqueous phase 
(1 µL) was used as template in 20 µL PCR reactions. PCR primers were designed to bind upstream and 
downstream of the genomic integration sites as well as within the integrated expression/deletion 
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cassette. For analyzing integrations of multiple expression cassettes, additional primers were 
designed to produce amplicons covering the junctions between the individual integrated expression 
cassettes. After each integration step, the presence of all previously integrated expression cassettes 
was verified. 
2.7 Media and cultivation conditions for the production of 1,2-PDO from glycerol 
Media used for shake flask batch cultivations assessing 1,2-PDO production were synthetic or 
complex media containing 60 mL L-1 glycerol as the sole carbon source. The synthetic medium 
according to Verduyn et al. (1992) contained 3 g L-1 KH2PO4, 0.5 g L
-1 MgSO4.7H2O, 15 mg L
-1 EDTA, 
4.5 mg L-1 ZnSO4.7H2O, 0.84 mg L
-1 MnCl2.2H2O, 0.3 mg L
-1 CoCl2.6H2O, 0.3 mg L
-1 CuSO4.5H2O, 
0.4 mg L-1 NaMoO4.2H2O, 4.5 mg L
-1 CaCl2.2H2O, 3 mg L
-1 FeSO4.7H2O, 1 mg L
-1 H3BO3, and 0.1 mg L
-1 KI. 
In case ammonium sulfate was used as the nitrogen source 5 g L-1 (NH4)2SO4 was added. After heat 
sterilization, an appropriate aliquot of vitamin stock solution was added. The final concentrations of 
vitamins were 0.05 mg L-1 D-(+)-biotin, 1 mg L-1 D-pantothenic acid hemicalcium salt, 1 mg L-1 nicotinic 
acid, 25 mg L-1 myo-inositol, 1 mg L-1 thiamine chloride hydrochloride, 1 mg L-1 pyridoxine 
hydrochloride, and 0.2 mg L-1 4-aminobenzoic acid. In case urea was used as the nitrogen source, an 
appropriate aliquot of a stock solution was added after heat sterilization to obtain a final 
concentration of 2.8 g L-1. For buffering the synthetic medium, 100 mM of potassium hydrogen 
phthalate was added to the medium prior autoclaving. The pH of the synthetic glycerol medium was 
adjusted to 4.0 (for non-buffered medium) and to 5.0 (for medium buffered with potassium 
hydrogen phthalate) with 2 M H3PO4. A pH of 4-5 was previously determined to be optimal for the 
growth on glycerol of wild-type CBS 6412-13A (unpublished results). The complex media used were 
YPG6% containing 10 g L
-1 yeast extract, 20 g L-1 peptone and 60 mL L-1 glycerol or YG containing only 
10 g L-1 yeast extract in addition to 60 mL L-1 glycerol. The pH of the complex media was adjusted to 
6.0 with 2 M H3PO4. Except for the strain PDO-FPS-TPI1down-DHA-EcmgsA2, all liquid media were 
supplemented with 30 mg L-1 phleomycin for plasmid maintenance. 
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For pre-cultivation, cells from a single colony were generally used to inoculate 3 mL of the respective 
medium in a 10 mL glass tube and incubated at orbital shaking of 200 rpm and 30°C for 24 (complex 
glycerol medium) to 48 h (synthetic glycerol medium). The pre-culture was used to inoculate 10 mL 
of the same medium in a 100 mL Erlenmeyer flask adjusting an OD600 of 0.2. This intermediate culture 
was cultivated at the same conditions until an OD600 of ~2.0 was reached. The appropriate culture 
volume (in order to later adjust an OD600 of 0.2 in 50 mL of medium) was centrifuged at 800 g for 
5 min and the supernatant discarded. The cell pellet was then resuspended in 50 mL of the 
respective glycerol-containing medium in a 500 mL Erlenmeyer flask. The main cultures were 
incubated at orbital shaking of 200 rpm and 30°C and samples for OD600 determination and HPLC 
analysis were taken at regular time intervals. 
2.8 Cultivations in controlled bioreactors 
All reactor-based cultivations were carried out using Sartorious 1 L bioreactors (Sartorious, Stedim 
Biotech, Göttingen, Germany) with equivalent working volumes and equipped with 2 Rushton six-
blade disc turbines. The pH electrode (Mettler Toledo, OH, USA) was calibrated according to 
manufacturer’s standard procedures and pH was controlled by automatic addition of 2 M NaOH and 
H2SO4. The bioreactor was sparged with sterile atmospheric air and the temperature was maintained 
at 30°C throughout the cultivations. Culture conditions were: pH 5, stirring rate: 800 rpm and air 
flow: 1 volume of air per volume of liquid per minute (vvm). Samples were taken across the 
exponential growth phase to monitor growth (OD600) as well as for HPLC analysis for metabolite 
profiling. 
2.9 Analytical methods 
Samples of culture supernatants were first filtered through 0.2 µm Minisart RC membrane filters 
(Sartorius) and stored at -20°C until analysis. The concentrations of glycerol, 1,2-PDO and ethanol in 
culture media were determined using a Waters HPLC system (Eschborn, Germany) equipped with 
two consecutive Aminex HPX-87H cation-exchange columns (Biorad, München, Germany) using 
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5 mM H2SO4 as the mobile phase at a flow rate of 0.45 mL min-1 and a column temperature of 45°C. 
Volumes of 20 μL of sample were used for injection. All components were detected using the Waters 
2414 Refractive Index detector. Under these conditions, the retention times were 35.6 min for 
glycerol, 45.4 min for 1,2-PDO and 57.7 min for ethanol. For quantification, standards were run in 
appropriate concentrations (i.e. between 1 g L-1 and 100 g L-1 for glycerol, 0.075 g L-1 and 5 g L-1 for 
1,2-PDO, and 0.394 g L-1 and 39.37 g L-1 for ethanol). The obtained raw data were processed using the 
Breeze 2 software (Waters). 
3. RESULTS 
3.1 Modular metabolic engineering of S. cerevisiae for the production of 1,2-PDO from glycerol 
All metabolic engineering steps in this study were conducted in the genetic background of our 
previously described and intensively studied haploid meiotic segregant CBS 6412-13A originating 
from the glycerol-utilizing wild-type S. cerevisiae strain CBS 6412 (Swinnen et al., 2016). This strain 
exhibiting a µmax of 0.13 h
-1 in synthetic glycerol medium was the best-performing glycerol-utilizing 
S. cerevisiae strain available to us at the time when the current study has been initiated. As 
demonstrated in our previous study, the strain CBS 6412-13A solely utilizes the native FAD-
dependent G3P pathway for glycerol catabolism (Swinnen et al., 2013). 
As. S. cerevisiae does not produce 1,2-PDO naturally, the first engineering module implemented 
during strain construction was the expression of the so-called `methylglyoxal pathway´ (see section 1 
and Figure 1). The key enzyme of this pathway is methylglyoxal synthase (MGS) and several previous 
studies have shown that even the sole expression of E. coli mgsA in S. cerevisiae resulted in the 
production of small amounts of 1,2-PDO (Hoffman, 1999; Jeon et al., 2009; Lee and DaSilva, 2006). 
Nevertheless, the additional expression of E. coli gldA encoding a glycerol dehydrogenase was 
demonstrated to increase 1,2-PDO production in S. cerevisiae (Hoffman, 1999). The E. coli aldehyde 
reductase encoded by yqhD was also considered here to be a useful enzyme for converting 
methylglyoxal to 1,2-PDO. The enzyme was shown to reduce methylglyoxal in vitro (Jarboe, 2011; Lee 
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et al., 2010) and has been successfully used to improve 1,2-PDO formation in engineered 
C. glutamicum additionally expressing E. coli mgsA and gldA (Siebert and Wendisch, 2015). 
Therefore, we decided to use codon-optimized versions of the E. coli genes mgsA, yqhD and gldA 
(referred to as EcmgsA, EcyqhD and EcgldA, respectively) in the current study and placed them 
between different S. cerevisiae promoters and terminators (see Material and Methods) in order to 
establish a `1,2-PDO module´ in yeast. All engineered strains harboring this module (referred to as 
`PDO´) carried head-to-tail genomic integrations of S. cerevisiae expression cassettes for EcmgsA and 
EcgldA, while the expression cassette for EcyqhD was expressed from a S. cerevisiae low-copy 
expression vector (see section 2.5 and Table 1).  
While establishing the module `PDO´, a parallel study in our laboratory revealed that the expression 
of a heterologous glycerol facilitator significantly improves the growth of strain CBS 6412-13A in 
synthetic glycerol medium (Klein et al., 2016b). As we assumed that an improved glycerol uptake 
might also be beneficial for 1,2-PDO production from glycerol, we decided to integrate an expression 
cassette bearing the coding sequence of FPS1 from Cyberlindnera jadinii (referred to here as CjFPS1) 
into the genome of all strains engineered for 1,2-PDO production. Accordingly, the term `FPS´ was 
included in the respective strain names (see section 2.5 and Table 1). The strain CBS 6412-13A 
expressing CjFPS1 was used as the negative reference throughout this study but CjFPS1 expression 
was not considered here as a separate module. 
A second module addressed the co-factor supply for 1,2-PDO formation. The three step conversion 
from DHAP to 1,2-PDO includes two enzymatic reactions that require reducing equivalents in the 
form of cytosolic NAD(P)H (Figure 1). As mentioned in the introduction (section 1), the native FAD-
dependent glycerol catabolic pathway (up to DHAP) in S. cerevisiae does not deliver cytosolic 
reducing equivalents. However, the pathway can be functionally replaced by an NAD+-dependent 
`DHA pathway´ as recently demonstrated by Klein et al. (2016a). The respective genetic modifications 
included the plasmid-based heterologous expression of glycerol dehydrogenase from Ogataea 
parapolymorpha (Opgdh), the overexpression of endogenous dihydroxyacetone kinase (DAK1) and 
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the deletion of endogenous glycerol kinase (GUT1). These modifications are collectively referred to 
as module `DHA´ in the respective strain names (Table 1). This module has been supposed to strongly 
increase cytosolic NADH availability for 1,2-PDO production since the FAD-dependent native pathway 
for glycerol catabolism has been completely abolished.  
An additional module addressed the need for increased availability of DHAP, the metabolic precursor 
for the `methylglyoxal pathway´. The introduction of the heterologous 1,2-PDO pathway creates a 
metabolic branch point at which MGS must compete with the endogenous glycolytic enzyme 
triosephosphate isomerase (TPI) (encoded by TPI1) for their common substrate DHAP. Jung et al. 
(2008) showed that the deletion of the TPI1 gene in S. cerevisiae bearing a heterologous 1,2-PDO 
pathway resulted in increased 1,2-PDO production in a medium containing a mix of glucose, 
galactose and ethanol as carbon sources. However, the complete abolishment of TPI activity is not 
feasible when glycerol serves as the sole source of carbon since this enzyme is essential to channel 
the carbon flux from the substrate glycerol into the central carbon metabolism (i.e. both glycolysis 
and gluconeogenesis). Therefore, a strategy for downregulating TPI1 expression (without fully 
abolishing it) via promoter replacement was employed. In a previous study, a collection of mutant 
promoters with gradually decreasing strengths (based on the constitutive TEF1 promoter) had been 
generated (Alper et al., 2005). Nevoigt et al. (2006) used this collection to develop sets of promoter 
replacement cassettes allowing the exchange of any promoter in the S. cerevisiae genome with a 
TEF1 promoter variant of defined strength. Two weak promoters from this collection (TEFmut7 and 
TEFmut2) have initially been tested in the current study (Figure S2 and the respective supplementary 
information), and we eventually selected the weakest promoter (TEFmut2) in order to replace the 
native TPI1 promoter. The respective genetic modification is referred to here as module `TPI1down´ 
(Table 1). The impact of the promoter replacement on growth of the corresponding intermediate 
strain in synthetic medium containing different carbon sources is shown in Figure S2 (supplementary 
information). These results are an indirect proof for the fact that the promoter replacement (using 
the TEFmut2 promoter) indeed resulted in decreased TPI activity. 
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3.2 The choice of cultivation medium strongly affected 1,2-PDO production of the engineered 
strains  
Our initial intention was to use synthetic glycerol medium for studying the impacts of the different 
engineering modules on 1,2-PDO production. We decided to use urea as the source of nitrogen in our 
synthetic medium as it, in contrast to ammonium sulfate, does not lead to medium acidification and 
is therefore known to result in much higher final optical densities compared to synthetic medium 
with ammonium sulfate. In the urea-containing medium, the strain PDO-FPS-TPI1down-DHA produced 
less than 0.2 g L-1 after 120 h of cultivation in synthetic glycerol medium (Figure 2A). Instead, 
significant concentrations of ethanol indicating an onset of fermentative metabolism were detected 
in the first half of the cultivation with a peak of up to 18 g L-1 after 72 h. Later, the ethanol 
concentration decreased (Figure 2B).  
In a previous study, Jung et al. (2011) successfully demonstrated the production of 1,2-PDO in 
engineered S. cerevisiae when using a complex medium (YPG containing 10 g L-1 yeast extract, 20 g L-1 
peptone, 10 g L-1glycerol and 1 g L-1 galactose). We therefore tested our advanced strain PDO-FPS-
TPI1down-DHA in YPG6% medium (10 g L
-1 yeast extract, 20 g L-1 peptone and 60 mL L-1 glycerol). 
However, only a slight improvement of 1,2-PDO production could be observed compared to synthetic 
medium with urea. The highest detected titer was ~0.3 g L-1 after 96 h of cultivation. Notably, the 
switch to YPG6% medium resulted in faster growth, glycerol consumption as well as ethanol 
production (Figure 2). Under these conditions, the strain accumulated up to 18 g L-1 ethanol already 
during the first 24 h of cultivation (Figure 2B).  
Surprisingly, omitting peptone from our YPG6% medium remarkably increased 1,2-PDO production 
from ~0.3 g L-1 to ~1.3 g L-1 where most of the product accumulated during the first 48 h (Figure 2A). 
The plausible nutrient limitation caused a much slower growth and is also reflected by a slower rate 
of glycerol consumption. Surprisingly, much less ethanol was produced in the absence of peptone 
(Figure 2B). On the basis of these results, we decided to first characterize the influence of the 
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different metabolic engineering modules on 1,2-PDO production in YG6% medium and dedicated 
separate experiments scrutinizing the medium effects on 1,2-PDO production. 
 
Figure 2 (2 column fitting image). Physiological characterization of strain PDO-FPS-TPI1down-DHA in three 
different cultivation media containing 60 mL L-1 glycerol as the sole carbon source. The strain carried all 
engineering modules as described in section 3.1. Cultivations were performed in 50 mL shake flask cultures and 
culture supernatants were analyzed by HPLC for the production of 1,2-propanediol (1,2-PDO) (A), ethanol (B) 
and the consumption of glycerol (C). Growth was recorded by determining the optical density of the cultures at 
a wavelength of 600 nm (OD600) (D). The different media used were SMG (synthetic defined glycerol medium 
containing urea as the nitrogen source), YPG (complex glycerol medium containing 1% yeast extract and 2% 
peptone) and YG (complex glycerol medium containing 1% yeast extract). All mean values and standard 
deviations are derived from at least three biological replicates. 
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3.3 The combination of modules DHA and TPI1down was crucial to achieve the highest concentration 
of 1,2-PDO in YG6% medium 
As mentioned in section 3.2, YG6% medium was used in order to characterize all constructed strains 
and dissect the impacts of the individual modules and their combinations on 1,2-PDO production and 
the cells’ physiology (Figure 3). 
 
Figure 3 (2 column fitting image). Physiological characterization of S. cerevisiae strains (derivatives of 
CBS 6412-13A) engineered for 1,2-PDO production from glycerol in YG medium containing 60 mL L-1 glycerol. 
Besides an expression cassette for the glycerol facilitator encoded by CjFPS1 (`FPS´), the analyzed strains 
carried the engineering module `PDO´ alone or in combination with the modules `DHA´ and `TPI1down´ as 
described in section 3.1. Cultivations were performed in 50 mL shake flask cultures and culture supernatants 
were analyzed by HPLC for the production of 1,2-PDO (A), ethanol (B) and the consumption of glycerol (C). 
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Growth was recorded by optical density measurements at 600 nm (D). Mean values and standard deviations 
were determined from at least three biological replicates. 
 
Compared to the control strain FPS, all strains bearing the `1,2-PDO module´ produced at least small 
amounts of 1,2-PDO (Figure 3 A). Interestingly, neither the sole downregulation of TPI1 expression 
(module `TPI1down´) nor the sole glycerol catabolic pathway replacement (module `DHA´) in the 
genetic background of the strain PDO-FPS resulted in a significant improvement of the 1,2-PDO titer. 
Only the combination of these two metabolic engineering modules with the `1,2-PDO module´ 
considerably improved 1,2-PDO production from less than 0.2 g L-1 to ~1.3 g L-1 when measured after 
120 h of cultivation. The results demonstrate that both above-mentioned modules were essential for 
1,2-PDO production from glycerol.  
The glycerol catabolic pathway replacement in strain PDO-FPS improved the strain’s glycerol 
consumption (Figure 3C, strains PDO-FPS-DHA and PDO-FPS-TPI1down-DHA) indicating that the DHA 
pathway allows a better flux from glycerol to DHAP compared to the G3P pathway present in the 
wild-type strain. In strain PDO-FPS-DHA, the increased glycerol consumption coincides with a faster 
growth, while the presence of the module `TPI1down´ seems to abrogate the growth supporting effect 
of module `DHA´ as visible in the growth curve for strain PDO-FPS-TPI1down-DHA (Figure 3D).  
Our data clearly show that the genetic manipulation mainly responsible for the production of ethanol 
observed in YG6% medium is the replacement of the endogenous glycerol catabolic pathway by the 
NADH-generating DHA pathway (Figure 3B). A switch to fermentative metabolism (visible by ethanol 
formation) is plausible when considering the excess of cytosolic NADH generated by the latter 
pathway. Again, the ethanol production was particularly high in the first half of the cultivation 
period, while its concentration declined during the second part of the cultivation (Figure 3B). During 
the second phase of cultivation, glycerol was still present and its concentration continued to 
decrease. Interestingly, the superior growth of strain PDO-FPS-DHA coincided with a strong decrease 
in ethanol concentration while the respective reduction in ethanol concentration during the second 
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cultivation half was very low in the strain with additional downregulation of TPI1 expression 
(Figure 3B). 
3.4 Implementation of a second expression cassette for E. coli MGS and analysis in controlled batch 
cultivation in bioreactors 
In the previous section, it was shown that the modules for cofactor-supply and carbon flux re-
direction (`DHA´ and `TPI1down´, respectively) were essential genetic manipulations to increase the 
capacity of S. cerevisiae to produce 1,2-PDO from glycerol. The next question that arose was whether 
the flux into the 1,2-PDO pathway was rate-controlling for 1,2-PDO production in the strain PDO-FPS-
TPI1down-DHA. At this stage, we decided to construct a strain that carries all genetic modifications 
within its genome (including the implementation of an additional expression cassette for E. coli 
mgsA) resulting in strain PDO-FPS-TPI1down-DHA EcmgsA2. This also facilitated the physiological 
characterization in larger volumes since no antibiotic had to be added anymore. When this strain was 
analyzed in shake flasks under the same conditions as used before, the additional EcmgsA expression 
cassette resulted in increased 1,2-PDO production (~2.5 g L-1 after 140 h of cultivation) while the 
maximum ethanol titer decreased from ~6.6 g L-1 to ~3.8 g L-1 as shown in Figure S3 (supplementary 
information).  
As a next step, the strain PDO-FPS-TPI1down-DHA EcmgsA2 was characterized under controlled 
conditions in batch cultivations in bioreactors using the same medium (YG6%). In general, the strain’s 
physiology was very similar to that observed in shake flask cultures. However, the controlled 
cultivation conditions allowed the cells to reach higher optical densities than in shake flasks. The 
maximum 1,2-PDO titer reached was ~4.3 g L-1 (Figure 4). This has been the highest reported 1,2-PDO 
titer obtained by fermentations with engineered S. cerevisiae.  
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Figure 4 (single column fitting image). Physiological characterization of strain PDO-FPS-TPI1down-DHA-
EcmgsA2 in batch cultivations in 1 L bioreactors using YG medium containing 60 mL L
-1 glycerol as the carbon 
source. The analyzed strain carried genomic integrations of all engineering modules, i.e. besides the glycerol 
facilitator encoded by CjFPS1 (`FPS´), the methylglyoxal pathway (`PDO´) including a second expression cassette 
for E. coli mgsA (EcmgsA2), the glycerol catabolic pathway replacement (`DHA´) and the replacement of the 
native TPI1 promoter by the weak TEF1 promoter variant TEFmut2 (`TPI1down´). One representative out of three 
experiments is shown. 
 
3.5 1,2-PDO production in buffered synthetic medium with ammonium sulfate as a carbon source 
The rather surprising results concerning the influence of the medium composition on the observable 
product pattern encouraged us to conduct a number of experiments in order to gain further insight 
into this phenomenon. The results (data not shown) revealed that the impact of medium 
components is very complex and most probably even strain dependent. Further experiments have to 
be carried out in order to dissect and understand the observed medium effects. Among the already 
performed experiments regarding medium effects, there has been one that was set to test whether 
glycerol fermentation is also visible in synthetic glycerol medium with ammonium sulfate as the 
nitrogen source as soon as a buffer is added and thereby rapid medium acidification is avoided 
resulting in significantly higher optical densities. This question came up after we detected significant 
ethanol production in our strains with the `DHA´ module (sections 3.2 and 3.3), a fact that has not 
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been recognized in our previous study regarding DHA pathway strains (Klein et al., 2016a). However, 
the earlier study was performed using unbuffered synthetic medium with ammonium sulfate as the 
nitrogen source. Therefore, 100 mM potassium phthalate buffer was added to synthetic medium 
containing either ammonium sulfate or urea. This allowed a direct comparison of the two nitrogen 
sources. The respective experiment was performed with the above-mentioned strain PDO-FPS-
TPI1down-DHA EcmgsA2 carrying two expression cassettes for EcmgsA and in which all genetic 
modifications were stably integrated into the genome. To our huge surprise, the buffered 
ammonium sulfate containing medium led to a significant formation of 1,2-PDO and a comparably 
low ethanol production which was in clear contrast to the results obtained for the urea-containing 
medium (Figure 5). The remarkable difference with regard to the 1,2-PDO/ethanol ratio between the 
two nitrogen sources (Figure 5A and B) cannot simply be explained by the obtained culture density 
(Figure 5A). In fact, the used nitrogen source seemed to have a (so far unknown) impact on the 
carbon flux distribution in our engineered strains.  
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Figure 5 (2 column fitting image). Influence of the used nitrogen source on the physiology of the S. cerevisiae 
strain PDO-FPS-TPI1down-DHA-EcmgsA2 engineered for 1,2-PDO production from glycerol in synthetic medium 
buffered with 100 mM potassium phthalate buffer. The initial pH of the media was set to 5.0. Cultivations 
were performed in 50 mL shake flask cultures and culture supernatants were analyzed by HPLC for the 
production of 1,2-PDO (A), ethanol (B) and the consumption of glycerol (C). Growth was recorded by optical 
density measurements at 600 nm (D). Mean values and standard deviations were determined from at least 
three biological replicates. 
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4. Discussion 
In this study, a novel metabolic engineering approach was used to produce 1,2-PDO in S. cerevisiae 
from glycerol as the sole carbon source. A previous attempt to establish 1,2-PDO production from 
glycerol in S. cerevisiae (equipped with the ‘methylglyoxal pathway’) focused on the overexpression 
of GUT1 and GUT2 which encode the enzymes for the native (FAD-dependent) glycerol catabolic 
pathway (Jung et al., 2011). However, the electrons stemming from glycerol oxidation through this 
pathway are eventually transferred to oxygen via the respiratory chain. In contrast, our current 
approach was based on the complete replacement of the endogenous G3P pathway by the NAD+-
dependent DHA pathway according to Klein et al. (2016a). This replacement has been supposed to 
provide cytosolic reducing equivalents from glycerol and facilitate the formation of fermentation 
products such as 1,2-PDO. The current study demonstrates that the module `DHA´ indeed increased 
the formation of the target product at least when TPI expression was reduced in parallel thereby 
increasing the availability of the precursor DHAP. Notably, downregulation of TPI expression alone 
did not result in significant 1,2-PDO formation. These results underline the importance of providing 
sufficient concentrations of both pre-cursor and co-factor for the successful re-direction of metabolic 
fluxes. The fact that 1,2-PDO production in the presence of increased pre-cursor and co-factor could 
be even further increased by a second mgsA expression cassette demonstrates that the flux through 
methylglyoxal synthase has been the rate-controlling step in the respective genetic background and 
might be one important target for further strain improvement.  
As already mentioned, the 1,2-PDO titer of ˃ 4 g/l achieved in the current study has been the highest 
reported for S. cerevisiae. This titer obtained in the bioreactor experiment in YG medium 
corresponded to a maximum product yield of ~129 ± 21 mg per g glycerol consumed. Jung et al. 
(2011) reported a 1,2-PDO yield of 213 mg per g glycerol consumed. However, their experiments 
were performed in modified YEPD medium (yeast extract 1%, peptone 2%, glycerol 1% and galactose 
0.1%). Although the galactose was only added for induction of gene expression in the latter study, its 
utilization as a carbon source may have falsified the calculated yields. Moreover, ingredients of the 
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added peptone might have also been used as minor carbon sources. These facts hamper a reliable 
comparison with our results.  
Regarding the pathway from DHAP to 1,2-PDO, there are several possible metabolic routes which 
may result in either R- or S-1,2-PDO (Figure 1). However, we have not dissected in our analytics so far 
whether only one or both enantiomers were formed by our engineered S. cerevisiae strains. In 
addition, it has been difficult to draw a strong hypothesis on the actual carbon flux solely based on 
published knowledge. First, the genes EcgldA and EcyqhD encode for enzymes with relatively broad 
substrate specificities (Jarboe, 2011; St. Martin et al., 1977; Tang et al., 1979). Second, the gene 
Opgdh originally used for the module ‘DHA’ might also contribute to the reductive reactions from 
methylglyoxal to 1,2-PDO to a certain degree since its expression (instead of EcgldA) in a PDOmin 
strain also increased 1,2-PDO formation as compared to the sole expression of EcmgsA (results not 
shown). Third, endogenous (probably rather unspecific) reductases of the yeast S. cerevisiae have 
also to be considered to be active in the respective chemical conversions as mentioned in section 1. 
Nevertheless, our 1,2-PDO producing strains formed a significant amount of an additional product as 
visible by a conspicuous peak in the HPLC (data not shown). HPLC analysis of the retention times of 
the pathway intermediates methylglyoxal, R-/S-lactaldehyde and acetol indicated that acetol might 
be the compound that was accumulated by our 1,2-PDO producer. The retention time of 
lactaldehyde under the employed conditions is close to that of glycerol and the latter was still 
present in relatively large concentrations in the medium at the end of the cultivation period in most 
of our experiments. Therefore, a peak for lactaldehyde is assumed to partially overlap with the peak 
for glycerol. At least, we did not recognize any shoulder for the glycerol peak in our chromatograms. 
Notably, other authors expressing the same E. coli genes for 1,2-PDO formation in C. glutamicum also 
reported significant acetol formation (Siebert and Wendisch, 2015), while Altaras and Cameron 
(1999) found R-lactaldehyde as an intermediate in an E. coli strain overexpressing E. coli mgsA and 
gldA. Future work including metabolomics will focus on a more comprehensive characterization of 
the carbon flow in our engineered strains. 
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Glycerol has been considered as a carbon source that is solely metabolized in a respiratory manner in 
S. cerevisiae. The full dependence of glycerol catabolism on respiration in wild-type S. cerevisiae 
strains can be explained by the fact that the electrons are directly transferred by Gut2 via FADH2 to 
the mitochondrial respiratory chain. This also holds for strains which display higher growth rates (and 
glycolytic flux) in synthetic glycerol medium than the majority of wild-type S. cerevisiae strains. In 
fact, Ochoa-Estopier et al. (2011) comprehensively studied an evolved derivative of CBS 8066 (FL20) 
that exhibited a µmax of 0.20 h
-1 in synthetic glycerol medium in a controlled bioreactor setup and no 
reduced fermentation products such as ethanol were detected. Similarly, no fermentation products 
were detected in shake-flask cultivations using our non-engineered wild-type S. cerevisiae strain 
CBS 6412-13A which is able to grow in synthetic glycerol medium with a µmax of 0.13 h
-1 via the G3P 
pathway (data not shown).  
In the view of the current study it is, however, important to note that the applied glycerol catabolic 
pathway replacement strategy rendered the strain’s glycerol catabolism solely dependent on NAD+. 
This has been assumed to result in surplus cytosolic NADH and to facilitate the production of 
fermentation products in our strains such as 1,2-PDO (heterologous pathway) and/or ethanol (S. 
cerevisiae’s major native fermentation product). Indeed, our data indicates that cells, which depend 
on the DHA pathway for glycerol catabolism, at least partially ferment the glycerol, even though both 
the degree of fermentation and the ratio between 1,2-PDO and ethanol formation are strain- and 
medium dependent.  
So far, we cannot dissect whether the surplus of cytosolic NADH caused the fermentative 
metabolism of glycerol right at the beginning of the cultivation or whether any kind of nutrient or 
oxygen limitation was an additional requirement for the metabolic switch. At least, one has to note 
that ethanol formation was also visible in the bioreactor experiment employing the YG6% medium 
where air was flushed with a rate of 1 vvm (stirring rate 800 rpm) into the culture. The underlying 
basis why 1,2-PDO is produced in significant amounts in YG6% medium (and in the buffered 
ammonium sulfate-containing synthetic medium) while only trace amounts of the target product 
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were formed in synthetic medium with urea as a nitrogen source and in YPG6% medium (where 
ethanol is the prominent fermentation product) has not been clarified yet. By unknown reasons, the 
engineered 1,2-PDO pathway can probably better compete with the endogenous ethanol formation 
pathway in the first two media. 
It has been very intriguing that the concentration of ethanol in the medium started to decrease at a 
certain point in time. In general, the actual ethanol concentration could have been affected by three 
different processes which might, at least partly, have occurred in parallel: i) ethanol formation, ii) 
evaporation and iii) ethanol consumption. Evaporation was tested in a parallel experiment using 
medium without cells and an initial ethanol concentration of 25 g L-1. Under the applied conditions, 
the ethanol evaporated with a maximum rate of ~0.10 g L-1 h-1. This rate was lower than observed for 
the decrease in ethanol concentration for the analyzed cultures which varied between 0.16 and 0.44 
g L-1 h-1. Although its impact can definitely not be neglected, evaporation can therefore not 
completely explain the observed decrease in ethanol concentration in our experiments. Thus, it can 
be concluded that ethanol might have been consumed together with glycerol and even further when 
glycerol was completely depleted (Figure 2). Assuming the actual occurrence of ethanol consumption 
by the cells, the observed decrease of the ethanol titer in the second cultivation period may have 
been caused by the fact that ethanol production by fermentation stopped (or at least slowed down) 
while respiratory ethanol utilization continued or even increased. A reduction in glycerol 
consumption rate at a later stage in the cultivation was also visible. Although we do not have a 
plausible explanation for this result, it might underpin our hypothesis with regard to a certain 
overflow metabolism at increased glycerol consumption rates. The lower glycerol consumption rate 
might have resulted in less NADH generation and the rate of respiration might have been sufficient 
to reoxidize the formed NADH explaining why the cells did not need fermentation at the later phase 
of cultivation. Nevertheless, we cannot exclude that regulatory mechanisms changed the rate of 
fermentation and/or respiration at this point in time and further work will be necessary to clarify this 
aspect. 
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The data presented in the current manuscript demonstrate that S. cerevisiae can be engineered to 
produce significant concentrations of 1,2-PDO (> 4 g L-1 in a controlled bioreactor set-up). Our study 
shows that both metabolic precursor and co-factor supply are essential for target product formation. 
The work also demonstrates the crucial impact of the medium composition and the experimental 
conditions on the metabolic mode and, thus product titer and yield. We therefore believe that there 
is still a lot of room for further improving 1,2-PDO production in S. cerevisiae.  
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Highlights 
 
 Highest reported 1,2-propanediol (1,2-PDO) titer for yeast (˃4 g L-1) from glycerol 
 NADH-generating glycerol catabolic pathway crucial for 1,2-PDO formation  
 Increased metabolic supply of precursor dihydroxyacetone phosphate essential 
 Strong impact of medium composition on 1,2-PDO to ethanol ratio 
 
 
